Omega Therapeutics Inc (OMGA) — Financial Flexibility Index
Omega Therapeutics Inc (OMGA) has a Financial Flexibility Index of -0.10x as of September 2024. Free cash flow of $-14.00 Million (operating CF $-14.02 Million minus capex $16.00K) represents 0% of total liabilities ($141.18 Million). Check Omega Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Omega Therapeutics Inc Financial Flexibility Index (2019–2023)
Historical Financial Flexibility Index trend for Omega Therapeutics Inc across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Omega Therapeutics Inc.
Annual Financial Flexibility Index for Omega Therapeutics Inc (2019–2023)
Year-by-year free cash flow to debt coverage for Omega Therapeutics Inc. Explore Omega Therapeutics Inc (OMGA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.61x | $-88.64 Million | $-91.51 Million | $146.35 Million | ▲ +75.0% |
| 2022 | -2.43x | $-97.14 Million | $-98.52 Million | $40.03 Million | ▼ -41.4% |
| 2021 | -1.72x | $-56.14 Million | $-57.61 Million | $32.70 Million | ▼ -554.3% |
| 2020 | -0.26x | $-24.32 Million | $-26.13 Million | $92.71 Million | ▲ +25.4% |
| 2019 | -0.35x | $-14.79 Million | $-15.68 Million | $42.04 Million | — |